Disease | multiple sclerosis |
Phenotype | C0035435|rheumatic disease |
Sentences | 2 |
PubMedID- 20864146 | Methods: all confirmed cases of demyelinating disease, optic neuritis, and multiple sclerosis (ms) in patients with rheumatic diseases treated with tnf-antagonists were reviewed from 3 different sources: (1) the spanish registry of biological therapies in rheumatic diseases (biobadaser); (2) the spanish pharmacovigilance database of adverse drug reactions (fedra); and (3) a systematic review (pubmed, embase, and the cochrane library). |
PubMedID- 22152489 | Methods: all confirmed cases of demyelinating disease, optic neuritis, and multiple sclerosis (ms) in patients with rheumatic diseases treated with tnf-antagonists were reviewed from 3 different sources: (1) the spanish registry of biological therapies in rheumatic diseases (biobadaser); (2) the spanish pharmacovigilance database of adverse drug reactions (fedra); and (3) a systematic review (pubmed, embase, and the cochrane library). |
Page: 1